Please login to the form below

Not currently logged in


This page shows the latest CGRP news and features for those working in and with pharma, biotech and healthcare.

Pfizer to acquire Biohaven in deal worth over $11bn

Pfizer to acquire Biohaven in deal worth over $11bn

Medicine. “Nurtec ODT, which is already the number one prescribed migraine medicine in its class in the US, coupled with Biohaven’s CGRP pipeline, offers hope for patients suffering from migraine

Latest news

More from news
Approximately 6 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    1. Rimegepant from BioHaven Pharmaceuticals is an antagonist of calcitonin gene-related peptide (CGRP), recently approved in the US for the acute treatment of migraine, with prevention trials also ongoing. ... Allergan’s Ubrelvy is the only other oral

  • Deal Watch January 2018

    Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... licence agreement in January with respect to calcitonin gene-related peptide

  • The good, the bad and the ugly The good, the bad and the ugly

    Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.

  • Deal Watch November 2015 Deal Watch November 2015

    455. Heptares. Teva. Licence drug-discovery agreement. Small molecule calcitonin gene-related peptide (CGRP) antagonists for migraine.

  • Pharma deals in July 2015 Pharma deals in July 2015

    related peptide (CGRP) receptor antagonist programme with the lead product at the end of phase II for treatment of migraine. ... 293. Merck / Allergan. Acquisition of R&D. Oral CGRP compounds (lead Phase 2) for migraine.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...